Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV

Risk of severe breakthrough COVID-19 infection is higher for people with HIV with moderately low CD4 cell counts johnshopkinssph jamanetworkopen

Keri N. Althoff, PhD, MPH, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Rm E7142, Baltimore, MD 20295 .Ms Humes and Dr Althoff had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.Acquisition, analysis, or interpretation of data:

Lang, Humes, Coburn, Horberg, Watson, Jefferson, Park, Gordon, Akgün, Justice, Napravnik, Edwards, Browne, Agil, Silverberg, Skarbinski, Leyden, Stewart, Hogan, Gebo, Marconi, Althoff.Critical revision of the manuscript for important intellectual content: Lang, Humes, Coburn, Horberg, Watson, Jefferson, Park, Gordon, Akgün, Justice, Napravnik, Edwards, Browne, Agil, Silverberg, Skarbinski, Leyden, Stewart, Hogan, Gebo, Marconi, Williams, Althoff.Obtained funding:Fathi, Park, Gordon, Akgün, Justice, Napravnik, Edwards, Browne, Agil, Skarbinski, Leyden, Stewart, Hogan, Gebo.Dr Lang reported receiving grants from Canadian Institutes of Health Research , Alberta Innovates, and the University of Calgary paid to their institution.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

medical_xpress /  🏆 101. in UK

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

What is the association of masking behavior with SARS-CoV-2 infection?What is the association of masking behavior with SARS-CoV-2 infection? GWtweets SARSCoV2 COVID19 Masking Mask FaceMasks
続きを読む »

The prevalence of COVID-19 vaccine hesitancy among the sub-Saharan adolescent populationThe prevalence of COVID-19 vaccine hesitancy among the sub-Saharan adolescent population PLOSGPH GeorgeMasonU UniIbadan Harvard COVID19 coronavirus covid vaccine
続きを読む »

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patientsMolnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients HKUniversity COVID19 SARSCoV2 Mortality Molnupiravir NirmatrelvirRitonavir
続きを読む »

Estimating the all-cause excess mortalities due to COVID-19In a new study, researchers estimated all-cause excess death rates due to the coronavirus disease 2019 (COVID-19) pandemic.
続きを読む »